Mark Slack shares his journey from gynecologist to co-founder of CMR Surgical, a company dedicated to making surgery safer and more accessible through robotics. The conversation covers:

• The Birth of CMR Surgical
• A Vision for Robotics
• Challenges in MedTech
• The Future of Surgical Robotics
• Commitment to Ethical Practices

Produced by Cambridge TV

Hosted on Acast. See acast.com/privacy for more information.

Paula Rogers-Brown joins the podcast to discuss the upcoming Cambridge Tech Week, set to take place from 15th to 19th September. This year's theme, "Seizing the AI Advantage," reflects the growing importance of AI across multiple sectors, including climate tech and clean tech.

What to Expect at Cambridge Tech Week:

• Diverse Programming: The week will feature a variety of events, including keynotes from industry leaders like Sir Nick Clegg and Margaret Heffernan, as well as a pitching competition showcasing five innovative startups.

• Innovation Alley: This year, Innovation Alley will span two days, allowing attendees to engage with over 50 exhibitors and explore cutting-edge technologies. As the beating heart of Cambridge Tech Week, Faye encourages everyone to participate: "Get that bolt-on ticket and make sure you visit Innovation Alley."

• Networking Opportunities: Attendees can look forward to a Tech Leaders Dinner and a gala reception, providing excellent opportunities to connect with fellow tech enthusiasts and industry leaders.

Book your ticket here: https://cambridgetechweek.co.uk/

Produced by Cambridge TV

Hosted on Acast. See acast.com/privacy for more information.

In this week’s episode we dive into the exciting world of battery technology with Christoph Schnedermann, the founder and CEO of Illumion.

Christoph shares his academic journey, which spans from Jena to Oxford, Harvard, and finally Cambridge. He reflects on how these diverse environments shaped his entrepreneurial mindset.

We discuss:

• Illumion's Mission: Illumion focuses on revolutionising battery research with its charge photometry platform, which allows real-time analysis of ion movement within batteries. Christoph explains, “We wanted to provide a lens into the inner workings of a battery at the R&D stage, where there is a critical gap.”

• Market Opportunities: The R&D sector for batteries presents a significant market opportunity, especially as the demand for innovative battery materials grows.

• Challenges and Triumphs: Christoph candidly discusses the challenges of startup life, particularly in securing funding during tough market conditions. “Last year was very, very hard to raise. It is ultimately a very, very hard job and you can only do it if you're tenacious and believe in the idea that you have.”

• Future Plans: Looking ahead, Illumion aims to scale its manufacturing capabilities and expand its market reach. Christoph emphasises the importance of maintaining control over production: “It gives us the agility to respond quickly to different demands.”

Produced by Cambridge TV

Hosted on Acast. See acast.com/privacy for more information.

This week we are joined by Josephin Holstein, founder and CTO of Evoralis an early stage spin out from Cambridge University with the mission to enable true and sustainable plastic recycling.

Josephin shares her journey from academia to entrepreneurship, detailing how Evoralis is revolutionising plastic recycling through innovative enzyme technology.

Key insights:

• Josephin and her team, originally postdocs at the University of Cambridge, recognised the potential for their research in biochemistry to impact the circular economy.
• Evoralis develops enzymes that can efficiently break down various types of plastics, particularly in the textile industry. Josephin explains, “We can screen up to 10 million enzyme candidates per day, which is 1,000 times faster than conventional methods.” This rapid screening process is crucial for identifying effective solutions to plastic waste.
• The company is currently in the R&D phase, aiming to deliver its first enzymes within a year. Josephin emphasises the importance of collaboration, stating, “We need someone to produce our enzymes... we don’t want to build our own factory to recycle plastics.”
• Josephin candidly discusses the hurdles in the biotech landscape, particularly in securing investment. “You have to be persistent and patient,” she advises, sharing her experience of navigating investor conversations and the importance of demonstrating traction in the market.

Produced by Cambridge TV

Hosted on Acast. See acast.com/privacy for more information.

In this week’s episode, Andrew Williamson, Managing Partner of Cambridge Innovation Capital (CIC), shares his insights on the UK government’s spin-out review and the evolving landscape of venture capital in Cambridge.

Some standout moments include:

• The importance of proof-of-concept funding: Andrew highlights the critical need for proof-of-concept funding to bridge the gap between fundamental research and commercialisation. He states, “Proof of concept funding is essential for advancing technology far enough to attract both large corporations and investors.”

• Evolving equity terms: The conversation touches on the need for universities to adopt more founder-friendly equity terms. Andrew notes, “The sentiment in the sector has improved, and we’re starting to see equity allocations fall, which is encouraging for founders and investors alike.”

• Celebrating entrepreneurship: Andrew emphasises the importance of promoting entrepreneurship as an aspirational career path. He reflects, “We need to do a better job of celebrating our entrepreneurs and the breakthroughs they achieve.”

Produced by Cambridge TV

Hosted on Acast. See acast.com/privacy for more information.

This week on Cambridge Tech Podcast, we sit down with Sabesan Sithamparanathan, founder and president of PervasID, to talk about how a passion for innovation, and a background shaped by a journey from Sri Lanka to Cambridge, led to pioneering advances in RFID technology.

In the episode, Sabesan breaks down how battery-free RFID is quietly transforming major industries:

• Retail: Tackling theft and stock issues while boosting sales with real-time inventory tracking
• Aerospace: Preventing tool loss and reducing foreign object debris to improve safety and save billions
• Healthcare: Ensuring critical medical equipment is always accounted for, improving patient outcomes
• 
  

He also shares the reality of turning lab research into a commercial product, the power of strategic partnerships, and how PervasID is positioning itself for global scale.

Plus, Sabesan reflects on his commitment to STEM education and the role tech companies can play in shaping future learning, especially in a world increasingly influenced by AI.

Produced by Cambridge TV

Hosted on Acast. See acast.com/privacy for more information.

Have you ever thought about the massive impact of insect infestations on our world?

Robert Fryers, CEO of Spotta, shared some incredible insights on how their innovative early warning systems are revolutionising pest control. From humble beginnings in 2013 to now operating in 24 countries, Spotta is making waves in the tech world.

Robert's journey is a testament to the power of innovation and perseverance. From navigating the challenges of COVID-19 to securing investment and expanding their product range, Spotta's story is truly inspiring.

Key Insights

The pest control market is vast, with insect infestations causing about half a trillion dollars in damage annually. Spotta's technology addresses this significant market opportunity

Spotta's first product targeted bedbugs in hotels, but the company has since expanded to other sectors like forestry, agriculture, and horticulture

Spotta uses ultra-low power vision systems for real-time monitoring of insects. This technology is designed to be cost-effective and sustainable, running for up to a year on an alkaline battery

The company is committed to reducing the use of chemical insecticides, which aligns with global regulatory pressures and the need for more sustainable pest control solutions

Robert expresses a desire for Spotta to become a unicorn. He believes that the scale of the problem they are addressing, combined with their unique technology and market position, makes this goal achievable.

Produced by Cambridge TV

Hosted on Acast. See acast.com/privacy for more information.

What happens when a San Francisco VC takes the reins at Cambridge Enterprise?

Six months into the role, Jim Glasheen joins us to talk about his early moves as incoming CEO, like opening a London office to better plug Cambridge into global capital and talent flows. But this episode goes deeper than strategy.

Key takeaways:

• Cambridge has over 40 entrepreneurship programmes, but Jim questions if we’re at risk of creating an “illusion of entrepreneurship” without real market pressure.

• There’s a persistent Series B funding gap. His push? Build international investor relationships before companies need to scale.

• He wants the ecosystem to get more comfortable with failure and take on more risk.

• Cambridge Enterprise now spans licensing, founder support, venture investment, consulting, and ecosystem-building.

Jim’s set the clock ticking: in 6 months, he’ll report back on how international outreach and risk appetite are shifting. For now, he's off to the BIO conference in Boston to keep building those global ties.

Listen in for a sharp, honest look at what Cambridge needs next, and how leadership is setting the tone.

Produced by Cambridge TV

Hosted on Acast. See acast.com/privacy for more information.

This week James sits down with David Cleevely to explore the concept of serendipity and its role in innovation. David’s insights are not only thought-provoking but also practical for anyone looking to foster creativity and collaboration in their ventures.

Key Takeaways:

• David challenges the traditional notion of serendipity as mere luck. He asserts, “Serendipity doesn’t happen by accident. It’s much more by design.” This perspective encourages us to create environments that increase the likelihood of unexpected, beneficial encounters.

• He emphasises the need for organisations to rethink their structures and networks to facilitate serendipitous interactions. “You want to actually design things so that the unpredictable is going to happen,” he explains.

• The book is aimed at those frustrated with slow innovation in large organisations, including civil servants and corporate leaders. David’s goal is to inspire a shift in mindset towards embracing unpredictability in the innovation process.

• He shares his experience of writing the book, highlighting the collaboration with a personal trainer-like figure who helped him structure his thoughts and ideas effectively.

• David also provides practical frameworks for fostering serendipity within teams and organisations, encouraging listeners to consider how they can engineer opportunities for chance encounters.

The episode then features highlights from David’s previous appearance on the podcast in November 2024 (episodes 112 and 113), pulling together serendipity related highlights from that conversation to celebrate the book launch.

Produced by Cambridge TV

Hosted on Acast. See acast.com/privacy for more information.

This week’s episode features a fascinating interview with Nazmus Tareque and Raoul Peltier, co-founders of AnthroTek, a startup that is pushing the boundaries of material science in medical and robotics applications.

Nazmus and Raoul come from very different worlds - law and VC on one side, drug delivery and materials science on the other - but together they’re building hyper-realistic silicone solutions for real world impact.

A few standout moments from the conversation:

🧠 “We started with this idea of what the market might need, and very early on, we realised the demand is not for hyperrealism, but for functionality.” – Raoul

🌍 “We want to stay a humane company that finds solutions that help people and the planet.” – Nazmus

Key Takeaways from the Interview:

• The duo emphasised the importance of market discovery, stating, “We literally started with a lot of ideas and we didn’t know which one was going to work.” This approach has allowed them to refine their focus on medical applications, which currently account for 80% of their revenue.

• Both founders are passionate about sustainability, aiming to develop biodegradable alternatives to traditional silicone. “We are really interested in using our material science knowledge to explore can we find within five years an alternative to silicone that is actually biodegradable,” Nazmus shared.

• The Cambridge tech scene has played a pivotal role in their success and they highlighted the importance of networking and collaboration.

Produced by Cambridge TV

Hosted on Acast. See acast.com/privacy for more information.